Visionary Venture Fund

Profile

Visionary Venture Fund is a venture capital firm based in Newport Beach, California, with a primary focus on life sciences, particularly in ophthalmology and medical aesthetics. The firm collaborates with Key Opinion Leaders (KOLs), industry experts, and strategic acquirers to gather unparalleled insights, enabling informed investment decisions. This partnership approach sets them apart by leveraging specialized expertise and industry connections to add value to their portfolio companies.

The firm targets investments in companies addressing unmet or underserved markets, focusing on societal impact alongside financial returns. Visionary Venture Fund invests across early to late stages, with a particular emphasis on Series A to commercialization stages, offering check sizes from $5 million to $15 million. The firm operates with a significant focus on the U.S. market, specifically partnering with companies that show potential for significant impact in their targeted sectors.

Notable investments include Aurion Biotech, which focuses on innovative cell therapy for corneal endothelial disease, and Re-Vana Therapeutics, known for its collaboration with a major pharmaceutical firm. Other investments span across emerging technologies within their niche, reflecting their strategic emphasis on transformation in life sciences.